{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T20:58:24Z","timestamp":1769633904875,"version":"3.49.0"},"reference-count":141,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Emerging Drugs"],"published-print":{"date-parts":[[2021,4,3]]},"DOI":"10.1080\/14728214.2021.1916468","type":"journal-article","created":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T13:08:17Z","timestamp":1618837697000},"page":"131-147","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":8,"title":["Emerging drugs for the treatment of triple-negative breast cancer: a focus on phase II immunotherapy trials"],"prefix":"10.1080","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0057-5985","authenticated-orcid":false,"given":"Peter E.","family":"Hall","sequence":"first","affiliation":[{"name":"Dept. Of Medical Oncology, Barts Health NHS Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Schmid","sequence":"additional","affiliation":[{"name":"Dept. Of Medical Oncology, Barts Health NHS Trust, London, UK"},{"name":"Barts Cancer Institute, Queen Mary University of London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2021,4,19]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21492"},{"key":"cit0002","unstructured":"Global Caner Observatory. Cancer tomorrow. [cited 2020 Sep 20]. Available from: https:\/\/gco.iarc.fr\/tomorrow\/home."},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz173"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy192"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mds187"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.25.9820"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.46.1574"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-016-4059-6"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1809615"},{"key":"cit0010","unstructured":"National Comprehensive Cancer Network (NCCN). NCCN guidelines breast cancer. 2020. [cited 2020 Sep 20]. Available from: https:\/\/www.nccn.org\/professionals\/physician_gls\/default.aspx#breast."},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62422-8"},{"key":"cit0012","unstructured":"Food and Drug Administration (FDA). Clinical trial endpoints for the approval of cancer drugs and biologics guidance for industry. 2018. [cited 2020 Sep 20]. Available from: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/clinical-trial-endpoints-approval-cancer-drugs-and-biologics."},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-3492"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-20-1792"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30111-6"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70160-3"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1910549"},{"issue":"10257","key":"cit0018","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S0140-6736(20)31953-X","volume":"396","author":"Mittendorf EA","year":"2020","journal-title":"Lancet"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1612645"},{"issue":"12","key":"cit0020","first-page":"Cd008792","volume":"18","author":"Dear RF","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdn781"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0009-7"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.24.4244"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.12.6557"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdr405"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(07)70041-4"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw203"},{"issue":"4","key":"cit0028","first-page":"S1142","volume":"20","author":"Miles D","year":"2020","journal-title":"Ann Oncol"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32531-9"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4029-y"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-014-2980-0"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1706450"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1802905"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz012"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.08.2098"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1200\/jco.20.02151"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1381"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa072113"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.21.6457"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.28.0982"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.34.1255"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2016.09.024"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-3321"},{"key":"cit0044","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.08.2245"},{"key":"cit0045","doi-asserted-by":"publisher","DOI":"10.1038\/nrd4571"},{"key":"cit0046","unstructured":"Fortune Business Insights. Breast cancer therapeutics market size, share and industry analysis by therapy (Targeted therapy, hormonal therapy, chemotherapy), by distribution channel (Hospital pharmacies, retail pharmacies, online pharmacies), by cancer type (Hormone receptor, HER2+), and regional forecast, 2019-2026. 2020. [cited 2020 Sep 20]. Available from: https:\/\/www.fortunebusinessinsights.com\/industry-reports\/breast-cancer-therapeutics-market-100163."},{"key":"cit0047","unstructured":"FutureWise Research. Triple negative breast cancer treatment market by drug type, by distribution channel, and by region: industry analysis, market share, revenue opportunity, competition and forecast 2020-2027. 2020. [cited 2020 Oct 02]. Available from: https:\/\/www.futurewiseresearch.com\/healthcare-market-research\/Triple-Negative-Breast\/249."},{"key":"cit0048","unstructured":"Verified Market Research. Global immunotherapy drugs market by therapy area (Cancer, autoimmune and inflammatory diseases, infectious diseases), by end user (Hospitals, clinics), by type of drug (monoclonal antibodies, adult vaccines, preventive vaccines, therapeutic vaccines, checkpoint inhibitors, interferons alpha & beta, interleukins), by geographic scope & forecast. 2020. [cited 2020 Sep 20]. Available from: https:\/\/www.verifiedmarketresearch.com\/product\/immunotherapy-drugs-market\/."},{"key":"cit0049","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)17494-1"},{"key":"cit0050","doi-asserted-by":"publisher","DOI":"10.1111\/tbj.13525"},{"key":"cit0051","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2016.66"},{"key":"cit0052","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0157368"},{"key":"cit0053","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.18.1370"},{"key":"cit0054","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-0432"},{"key":"cit0055","doi-asserted-by":"publisher","DOI":"10.1172\/JCI45014"},{"key":"cit0056","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-031210-101324"},{"key":"cit0057","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.5022.779"},{"key":"cit0058","doi-asserted-by":"publisher","DOI":"10.1038\/ni1102-991"},{"key":"cit0059","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.02.013"},{"key":"cit0060","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)58737-6"},{"key":"cit0061","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1490019"},{"key":"cit0062","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-017-0458-3"},{"key":"cit0063","doi-asserted-by":"publisher","DOI":"10.1126\/science.271.5256.1734"},{"key":"cit0064","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.192461099"},{"key":"cit0065","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1992.tb05481.x"},{"key":"cit0066","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1003466"},{"key":"cit0067","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-019-0133-7"},{"key":"cit0068","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30904-X"},{"key":"cit0069","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)00587-0"},{"key":"cit0070","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-13-0127"},{"key":"cit0071","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1200690"},{"key":"cit0072","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2019.11.010"},{"key":"cit0073","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-16-0170"},{"key":"cit0074","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy518"},{"key":"cit0075","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy517"},{"key":"cit0076","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2018.4224"},{"key":"cit0077","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz394.010"},{"key":"cit0078","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2019-000433"},{"issue":"4","key":"cit0079","first-page":"9","volume":"80","author":"Locke G","year":"2020","journal-title":"Cancer Res"},{"key":"cit0080","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1990.20"},{"key":"cit0081","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21124427"},{"issue":"13","key":"cit0082","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1158\/1538-7445.AM2019-2391","volume":"79","author":"Overdijk MB","year":"2019","journal-title":"Cancer Res"},{"key":"cit0083","doi-asserted-by":"publisher","DOI":"10.1093\/glycob\/cwm049"},{"key":"cit0084","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0374-x"},{"issue":"1","key":"cit0085","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1158\/2159-8290.CD-RW2019-170","volume":"10","year":"2020","journal-title":"Cancer Discov"},{"key":"cit0086","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2019.6650"},{"key":"cit0087","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz158"},{"key":"cit0088","unstructured":"Roche. Roche provides update on Phase III study of Tecentriq in combination with paclitaxel for people with metastatic triple-negative breast cancer. 2020. [cited 2020 Sept 20th]. Available from: https:\/\/www.roche.com\/media\/releases\/med-cor-2020-08-06.htm"},{"key":"cit0089","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2019-000173"},{"key":"cit0090","doi-asserted-by":"publisher","DOI":"10.1038\/nri2216"},{"key":"cit0091","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2015.10.012"},{"key":"cit0092","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0432-4"},{"key":"cit0093","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz133"},{"key":"cit0094","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-15-0283"},{"key":"cit0095","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2017.02.001"},{"key":"cit0096","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-19-0545"},{"key":"cit0097","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-14-2277"},{"issue":"13","key":"cit0098","doi-asserted-by":"crossref","first-page":"CT049","DOI":"10.1158\/1538-7445.AM2019-CT049","volume":"79","author":"Schmid P","year":"2019","journal-title":"Cancer Res"},{"key":"cit0099","doi-asserted-by":"publisher","DOI":"10.1038\/nature11412"},{"key":"cit0100","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-1125"},{"key":"cit0101","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2019.37.15_suppl.1013"},{"key":"cit0102","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-18-1218"},{"key":"cit0103","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15364-z"},{"key":"cit0104","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2019.1029"},{"key":"cit0105","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30324-7"},{"key":"cit0106","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aak9670"},{"key":"cit0107","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aak9679"},{"key":"cit0108","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-000696"},{"key":"cit0109","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-1620"},{"key":"cit0110","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-1922"},{"key":"cit0111","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-1243"},{"key":"cit0112","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0806075105"},{"key":"cit0113","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-017-0257-y"},{"key":"cit0114","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0050946"},{"key":"cit0115","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2014.05.016"},{"key":"cit0116","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07387-4"},{"key":"cit0117","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2018.8"},{"key":"cit0118","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2541"},{"key":"cit0119","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0179431"},{"key":"cit0120","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2019.37.8_suppl.26"},{"key":"cit0121","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-018-0360-8"},{"key":"cit0122","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2019-000342"},{"key":"cit0123","doi-asserted-by":"publisher","DOI":"10.1111\/cas.14510"},{"key":"cit0124","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-020-05638-x"},{"key":"cit0125","doi-asserted-by":"publisher","DOI":"10.3892\/or.2012.1906"},{"key":"cit0126","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11040521"},{"issue":"3","key":"cit0127","first-page":"2813","volume":"16","author":"Tang M","year":"2018","journal-title":"Oncol Lett"},{"key":"cit0128","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-0347"},{"key":"cit0129","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-011-1192-2"},{"key":"cit0130","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.34.15_suppl.1086"},{"key":"cit0131","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-13-0896"},{"issue":"4","key":"cit0132","first-page":"1","volume":"80","author":"Han H","year":"2020","journal-title":"Cancer Res"},{"key":"cit0133","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-2822"},{"key":"cit0134","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.02318"},{"key":"cit0135","doi-asserted-by":"publisher","DOI":"10.1038\/35021093"},{"key":"cit0136","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2014.444"},{"key":"cit0137","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-13-0286"},{"key":"cit0138","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.03.041"},{"key":"cit0139","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz394.009"},{"key":"cit0140","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21134579"},{"key":"cit0141","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23930"}],"container-title":["Expert Opinion on Emerging Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14728214.2021.1916468","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,24]],"date-time":"2022-12-24T18:03:22Z","timestamp":1671905002000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14728214.2021.1916468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,3]]},"references-count":141,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4,3]]}},"alternative-id":["10.1080\/14728214.2021.1916468"],"URL":"https:\/\/doi.org\/10.1080\/14728214.2021.1916468","relation":{},"ISSN":["1472-8214","1744-7623"],"issn-type":[{"value":"1472-8214","type":"print"},{"value":"1744-7623","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iemd20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iemd20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-12-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}